Haw Par Corporation Limited (SGX:H02)

Market Cap	3.47B +32.4%
Revenue (ttm)	229.97M -6.1%
Net Income	265.46M +16.3%
EPS	1.20 +16.3%
Shares Out	221.37M
PE Ratio	13.08
Forward PE	12.58
Dividend	0.40 (2.58%)
Ex-Dividend Date	May 5, 2026

Volume	238,200
Open	15.49
Previous Close	15.49
Day's Range	15.32 - 15.72
52-Week Range	11.56 - 18.27
Beta	0.16
Analysts	Strong Buy
Price Target	20.60 (+31.29%)
Earnings Date	Aug 11, 2026

About Haw Par Corporation

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties. In addition, it provides family and tourist oriented leisure activities primarily in the form of oceanariums. Further, ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1969
• Employees: 595
• Stock Exchange: Singapore Exchange
• Ticker Symbol: H02

Financial Performance

In 2025, Haw Par Corporation's revenue was 229.97 million, a decrease of -6.07% compared to the previous year's 244.82 million. Earnings were 265.46 million, an increase of 16.29%.